← Open Payments lookup

STEPHANIE FISH: Open Payments

NPI 1952741845 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,362 in 138 payments from 14 companies in 2025. Trend: 2023 $2,526 · 2024 $2,439 · 2025 $2,362

Food & beverage: $2,362
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$490
ABBVIE INC.26$335
Alkermes, Inc.15$261
E.R. Squibb & Sons, L.L.C.15$234
Otsuka America Pharmaceutical, Inc.12$205
Neurocrine BioSciences, Inc.11$194
Axsome Therapeutics, Inc.8$167
Vanda Pharmaceuticals Inc.3$88
Takeda Pharmaceuticals U.S.A., Inc.4$86
Luye Pharma (USA) Ltd.3$82

Products named: CAPLYTA, VRAYLAR, COBENFY, ARISTADA, INGREZZA, Auvelity, ABILIFY ASIMTUFII, FANAPT.

Industry payments across FL — which companies pay providers there.